APA (7th ed.) Citation

Olsson-Brown, A., Jain, A., Frazer, R., Farrugia, D., Carser, J., Houghton, J., . . . Emanuel, G. (2025). Clinical Management and Outcomes of Immune-Related Adverse Events During Treatment with Immune Checkpoint Inhibitor Therapies in Melanoma and Renal Cell Carcinoma. Oncology and Therapy, 1. https://doi.org/10.1007/s40487-025-00349-z

Chicago Style (17th ed.) Citation

Olsson-Brown, Anna, Ankit Jain, Ricky Frazer, David Farrugia, Judith Carser, John Houghton, Ruth D. Lewis, Simon D’Mello, and Gabrielle Emanuel. "Clinical Management and Outcomes of Immune-Related Adverse Events During Treatment with Immune Checkpoint Inhibitor Therapies in Melanoma and Renal Cell Carcinoma." Oncology and Therapy 2025: 1. https://doi.org/10.1007/s40487-025-00349-z.

MLA (9th ed.) Citation

Olsson-Brown, Anna, et al. "Clinical Management and Outcomes of Immune-Related Adverse Events During Treatment with Immune Checkpoint Inhibitor Therapies in Melanoma and Renal Cell Carcinoma." Oncology and Therapy, 2025, p. 1, https://doi.org/10.1007/s40487-025-00349-z.